BostonGene Revenue and Competitors

Claim your profile

Lincoln, MA USA



Growjo Ranking



Estimated Revenue & Valuation

  • BostonGene's estimated annual revenue is currently $86.8M per year.(i)
  • BostonGene's estimated revenue per employee is $264,634
  • BostonGene's total funding is $200M.
  • BostonGene's current valuation is $1B. (April 2022)

Employee Data

  • BostonGene has 328 Employees.(i)
  • BostonGene grew their employee count by 17% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

BostonGene is an intelligent biomedical software platform that assists physicians in determining accurate immunological and targeted treatments, personalized for every patient. Despite tremendous advances in medical care, cancer remains the plague of our time. Part of the problem is the many cancer types and growing number of cases. But just as challenging for physicians is the overwhelming amount of new information on cancer treatments that is emerging nearly every day. BostonGene has created a unique solution that continuously collects the latest cancer research and clinical information, estimates the immune fitness and cancer characteristics of each patient, and transforms this knowledge into an automated, intelligent medical advisory system. Through our holistic approach to cancer treatment, BostonGene defines the optimal immunotherapy combination that is appropriate for each individual patient.

keywords:Healthcare, Health Care Information Technology, Personal Health


Total Funding


Number of Employees


Revenue (est)


Employee Growth %





BostonGene News

2022-04-06 - BostonGene Raises $150M in Series B Funding

BostonGene, a Waltham, MA-based personalized medicine company, closed a $150m Series B funding. NEC Corporation (NEC; TSE: 6701) led the...

2022-04-06 - BostonGene Announces Acceptance of Six Abstracts to be ...

“We look forward to showcasing our research at the AACR Annual Meeting. Our findings underscore the clinical utility of BostonGene's deep...

2022-04-06 - BostonGene Announces $150 Million Series B Funding at a ...

BostonGene's innovative computational platform performs AI-based molecular and immune profiling to discover correlations between tumor genomics,...

2019-09-08 - BostonGene Announces Partnership with National Institutes of ...

WALTHAM, Mass.--(BUSINESS WIRE)-- BostonGene Corporation (BostonGene), a biomedical software company, today announced its ...

2019-05-24 - BostonGene Wants to Be on "Cutting Edge" of Precision ...

With $50 million in its pocket, biomedical software startup BostonGene is refreshed and ready to take on the world of cancer treatment. The goal ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding